J. Safra Sarasin Holding Ag Alnylam Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.52 Trillion
- Q1 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 16,435 shares of ALNY stock, worth $4.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
16,435
Previous 19,142
14.14%
Holding current value
$4.5 Million
Previous $4.5 Billion
1.48%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding ALNY
# of Institutions
685Shares Held
109MCall Options Held
836KPut Options Held
784K-
Capital World Investors Los Angeles, CA16.6MShares$4.54 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.57 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.61 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.91 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.2 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...